Cargando…

NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor

CD94 is a C-type lectin expressed by natural killer (NK) cells and a subset of T cells. Blocking studies using anti-CD94 mAbs have suggested that it is a receptor for human leukocyte antigen class I molecules. CD94 has recently been shown to be a 26-kD protein covalently associated with an unidentif...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Andrew G., Posch, Phillip E., Scorzelli, Christopher J., Borrego, Francisco, Coligan, John E.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196137/
https://www.ncbi.nlm.nih.gov/pubmed/9034158
_version_ 1782148004226007040
author Brooks, Andrew G.
Posch, Phillip E.
Scorzelli, Christopher J.
Borrego, Francisco
Coligan, John E.
author_facet Brooks, Andrew G.
Posch, Phillip E.
Scorzelli, Christopher J.
Borrego, Francisco
Coligan, John E.
author_sort Brooks, Andrew G.
collection PubMed
description CD94 is a C-type lectin expressed by natural killer (NK) cells and a subset of T cells. Blocking studies using anti-CD94 mAbs have suggested that it is a receptor for human leukocyte antigen class I molecules. CD94 has recently been shown to be a 26-kD protein covalently associated with an unidentified 43-kD protein(s). This report shows that NKG2A, a 43-kD protein, is covalently associated with CD94 on the surface of NK cells. Cell surface expression of NKG2A is dependent on the association with CD94 as glycosylation patterns characteristic of mature proteins are found only in NKG2A that is associated with CD94. Analysis of NK cell clones showed that NKG2A was expressed in all NK cell clones whose CD16-dependent killing was inhibited by cross-linking CD94. The induction of an inhibitory signal is consistent with the presence of two immunoreceptor tyrosine-based inhibitory motifs (V/LXYXXL) on the cytoplasmic domain of NKG2A. Similar motifs are found on Ly49 and killer cell inhibitory receptors, which also transmit negative signals to NK cells.
format Text
id pubmed-2196137
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21961372008-04-16 NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor Brooks, Andrew G. Posch, Phillip E. Scorzelli, Christopher J. Borrego, Francisco Coligan, John E. J Exp Med Brief Definitive Report CD94 is a C-type lectin expressed by natural killer (NK) cells and a subset of T cells. Blocking studies using anti-CD94 mAbs have suggested that it is a receptor for human leukocyte antigen class I molecules. CD94 has recently been shown to be a 26-kD protein covalently associated with an unidentified 43-kD protein(s). This report shows that NKG2A, a 43-kD protein, is covalently associated with CD94 on the surface of NK cells. Cell surface expression of NKG2A is dependent on the association with CD94 as glycosylation patterns characteristic of mature proteins are found only in NKG2A that is associated with CD94. Analysis of NK cell clones showed that NKG2A was expressed in all NK cell clones whose CD16-dependent killing was inhibited by cross-linking CD94. The induction of an inhibitory signal is consistent with the presence of two immunoreceptor tyrosine-based inhibitory motifs (V/LXYXXL) on the cytoplasmic domain of NKG2A. Similar motifs are found on Ly49 and killer cell inhibitory receptors, which also transmit negative signals to NK cells. The Rockefeller University Press 1997-02-17 /pmc/articles/PMC2196137/ /pubmed/9034158 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Brief Definitive Report
Brooks, Andrew G.
Posch, Phillip E.
Scorzelli, Christopher J.
Borrego, Francisco
Coligan, John E.
NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
title NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
title_full NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
title_fullStr NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
title_full_unstemmed NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
title_short NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
title_sort nkg2a complexed with cd94 defines a novel inhibitory natural killer cell receptor
topic Brief Definitive Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196137/
https://www.ncbi.nlm.nih.gov/pubmed/9034158
work_keys_str_mv AT brooksandrewg nkg2acomplexedwithcd94definesanovelinhibitorynaturalkillercellreceptor
AT poschphillipe nkg2acomplexedwithcd94definesanovelinhibitorynaturalkillercellreceptor
AT scorzellichristopherj nkg2acomplexedwithcd94definesanovelinhibitorynaturalkillercellreceptor
AT borregofrancisco nkg2acomplexedwithcd94definesanovelinhibitorynaturalkillercellreceptor
AT coliganjohne nkg2acomplexedwithcd94definesanovelinhibitorynaturalkillercellreceptor